rs9870255

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1

The ENST00000433400.6(CTNNB1):​c.-665G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.401 in 152,000 control chromosomes in the GnomAD database, including 12,582 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.40 ( 12581 hom., cov: 32)
Exomes 𝑓: 0.75 ( 1 hom. )

Consequence

CTNNB1
ENST00000433400.6 5_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 2.76

Publications

11 publications found
Variant links:
Genes affected
CTNNB1 (HGNC:2514): (catenin beta 1) The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]
CTNNB1 Gene-Disease associations (from GenCC):
  • exudative vitreoretinopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • severe intellectual disability-progressive spastic diplegia syndrome
    Inheritance: AD, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Illumina, G2P, Ambry Genetics
  • exudative vitreoretinopathy 7
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.451 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CTNNB1ENST00000433400.6 linkc.-665G>C 5_prime_UTR_variant Exon 1 of 16 4 ENSP00000387455.2 P35222
CTNNB1ENST00000405570.6 linkc.-125+149G>C intron_variant Intron 1 of 16 2 ENSP00000385604.1 P35222
CTNNB1ENST00000642248.1 linkc.-128+149G>C intron_variant Intron 1 of 16 ENSP00000495244.1 P35222

Frequencies

GnomAD3 genomes
AF:
0.401
AC:
60906
AN:
151878
Hom.:
12575
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.329
Gnomad AMI
AF:
0.435
Gnomad AMR
AF:
0.365
Gnomad ASJ
AF:
0.382
Gnomad EAS
AF:
0.249
Gnomad SAS
AF:
0.407
Gnomad FIN
AF:
0.459
Gnomad MID
AF:
0.373
Gnomad NFE
AF:
0.456
Gnomad OTH
AF:
0.397
GnomAD4 exome
AF:
0.750
AC:
3
AN:
4
Hom.:
1
Cov.:
0
AC XY:
0
AN XY:
0
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
1.00
AC:
2
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.500
AC:
1
AN:
2
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.401
AC:
60942
AN:
151996
Hom.:
12581
Cov.:
32
AF XY:
0.397
AC XY:
29495
AN XY:
74260
show subpopulations
African (AFR)
AF:
0.329
AC:
13638
AN:
41416
American (AMR)
AF:
0.365
AC:
5583
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.382
AC:
1327
AN:
3470
East Asian (EAS)
AF:
0.249
AC:
1288
AN:
5170
South Asian (SAS)
AF:
0.406
AC:
1953
AN:
4812
European-Finnish (FIN)
AF:
0.459
AC:
4841
AN:
10548
Middle Eastern (MID)
AF:
0.377
AC:
110
AN:
292
European-Non Finnish (NFE)
AF:
0.456
AC:
30974
AN:
67972
Other (OTH)
AF:
0.394
AC:
832
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1840
3681
5521
7362
9202
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
574
1148
1722
2296
2870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.418
Hom.:
1708
Bravo
AF:
0.392
Asia WGS
AF:
0.367
AC:
1279
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.38
CADD
Benign
21
DANN
Benign
0.81
PhyloP100
2.8
PromoterAI
-0.0090
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9870255; hg19: chr3-41236581; API